RC-3095 is a bombesin/gastrin releasing peptide receptor antagonist.
RC-3095 is a synthetic peptide analog known for its role as a potent and selective antagonist of the gastrin-releasing peptide receptor (GRPR), a member of the bombesin receptor family. Structurally derived from bombesin-related peptides, RC-3095 is widely utilized in biochemical and pharmacological research to elucidate the physiological and pathological functions of GRPR signaling. Its high receptor affinity and specificity make it a valuable molecular tool for probing peptide-receptor interactions, dissecting signaling pathways, and advancing the understanding of regulatory mechanisms in various tissues. The compound's significance extends to studies of cellular communication, receptor pharmacology, and the broader field of peptide-mediated biological processes.
Receptor Pharmacology: RC-3095 is extensively employed in receptor binding assays and functional studies aimed at characterizing GRPR activity. By serving as a competitive antagonist, it enables researchers to selectively inhibit GRPR-mediated signaling, thereby facilitating detailed analysis of downstream effects triggered by endogenous bombesin-like peptides. These applications are critical for mapping receptor distribution, determining ligand specificity, and elucidating the molecular mechanisms underlying receptor activation and inhibition in both normal and disease-related contexts.
Signal Transduction Research: The compound is a key reagent in investigations of intracellular signaling cascades initiated by GRPR activation. Use of RC-3095 allows for precise modulation of peptide-induced responses, such as changes in second messenger levels, kinase activation, and gene expression profiles. This targeted inhibition supports efforts to unravel the complex networks governing cellular proliferation, differentiation, and secretory processes regulated by bombesin-like peptides, thereby advancing fundamental knowledge in cell biology and molecular pharmacology.
Peptide-Based Functional Studies: As a synthetic peptide antagonist, RC-3095 is instrumental in functional assays designed to assess the physiological roles of bombesin-related signaling in various organ systems. Researchers utilize the compound in ex vivo tissue preparations, cell culture experiments, and in vitro models to investigate processes such as neurotransmitter release, hormone secretion, and smooth muscle contractility. Its application enables the dissection of GRPR-dependent pathways and helps clarify the contributions of peptide signaling to homeostasis and cellular communication.
Peptide Antagonist Screening: RC-3095 serves as a reference compound in the development and validation of novel GRPR antagonists. Its well-characterized pharmacological profile provides a benchmark for comparative studies, supporting the screening of new synthetic peptides or small molecules for GRPR affinity and efficacy. This role is particularly valuable in early-stage drug discovery and in the optimization of peptide-based research tools, where reliable standards are essential for assay calibration and data interpretation.
Analytical Method Development: The compound is also used in the establishment and refinement of analytical techniques for quantifying peptide-receptor interactions. Its defined receptor selectivity and inhibitory properties make it suitable for use in radioligand binding assays, high-performance liquid chromatography (HPLC) protocols, and other analytical platforms. These applications contribute to the development of robust, reproducible methods for studying peptide pharmacology and receptor dynamics in complex biological samples, supporting both basic and applied research initiatives.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More